USD 0.06
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.44 Million USD | -5.12% |
2022 | 1.52 Million USD | -18.79% |
2021 | 1.87 Million USD | -23.57% |
2020 | 2.45 Million USD | 43.27% |
2019 | 1.71 Million USD | 54.37% |
2018 | 1.11 Million USD | 43.3% |
2017 | 774.89 Thousand USD | -9.17% |
2016 | 853.14 Thousand USD | -19.47% |
2015 | 1.05 Million USD | 6.44% |
2014 | 995.31 Thousand USD | 18.08% |
2013 | 842.91 Thousand USD | 17.04% |
2012 | 720.2 Thousand USD | 0.62% |
2011 | 715.79 Thousand USD | 67.84% |
2010 | 426.47 Thousand USD | 13.41% |
2009 | 376.05 Thousand USD | -17.01% |
2008 | 453.13 Thousand USD | -20.03% |
2007 | 566.59 Thousand USD | 162.04% |
2006 | 216.22 Thousand USD | -97.71% |
2005 | 9.43 Million USD | 43.32% |
2004 | 6.58 Million USD | 1802.79% |
2003 | 346.13 Thousand USD | -12.42% |
2002 | 395.21 Thousand USD | -15.36% |
2001 | 466.95 Thousand USD | -28.99% |
2000 | 657.55 Thousand USD | 27.57% |
1999 | 515.44 Thousand USD | 7.84% |
1998 | 477.95 Thousand USD | -20.74% |
1997 | 602.99 Thousand USD | 157.42% |
1996 | 234.24 Thousand USD | -15.33% |
1995 | 276.66 Thousand USD | 38.33% |
1994 | 200 Thousand USD | 0.0% |
1993 | 200 Thousand USD | -50.0% |
1992 | 400 Thousand USD | 0.0% |
1991 | 400 Thousand USD | 100.0% |
1990 | 200 Thousand USD | -33.33% |
1989 | 300 Thousand USD | 50.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 1.44 Million USD | -5.12% |
2023 Q4 | 1.51 Million USD | -1.48% |
2023 Q2 | 1.57 Million USD | 3.42% |
2023 Q1 | 1.52 Million USD | 9.6% |
2023 Q3 | 1.53 Million USD | -2.64% |
2022 Q4 | 1.39 Million USD | -1.52% |
2022 Q3 | 1.41 Million USD | -20.91% |
2022 Q2 | 1.78 Million USD | -4.86% |
2022 Q1 | 1.87 Million USD | 1.12% |
2022 FY | 1.52 Million USD | -18.79% |
2021 Q4 | 1.85 Million USD | -18.04% |
2021 Q3 | 2.26 Million USD | -3.51% |
2021 Q2 | 2.34 Million USD | -4.43% |
2021 Q1 | 2.45 Million USD | 23.26% |
2021 FY | 1.87 Million USD | -23.57% |
2020 Q4 | 1.99 Million USD | -4.26% |
2020 Q2 | 2.06 Million USD | 20.41% |
2020 Q1 | 1.71 Million USD | -11.15% |
2020 FY | 2.45 Million USD | 43.27% |
2020 Q3 | 2.08 Million USD | 0.82% |
2019 Q4 | 1.92 Million USD | -14.91% |
2019 Q2 | 2.08 Million USD | 87.65% |
2019 Q3 | 2.26 Million USD | 8.82% |
2019 Q1 | 1.11 Million USD | 31.23% |
2019 FY | 1.71 Million USD | 54.37% |
2018 Q2 | 756.53 Thousand USD | -2.37% |
2018 FY | 1.11 Million USD | 43.3% |
2018 Q3 | 846.43 Thousand USD | 11.88% |
2018 Q4 | 846.17 Thousand USD | -0.03% |
2018 Q1 | 774.89 Thousand USD | -2.62% |
2017 Q2 | 659.76 Thousand USD | -22.67% |
2017 FY | 774.89 Thousand USD | -9.17% |
2017 Q1 | 853.14 Thousand USD | -22.26% |
2017 Q3 | 791.53 Thousand USD | 19.97% |
2017 Q4 | 795.72 Thousand USD | 0.53% |
2016 Q3 | 835.77 Thousand USD | -20.66% |
2016 Q1 | 1.05 Million USD | 2.51% |
2016 Q2 | 1.05 Million USD | -0.57% |
2016 Q4 | 1.09 Million USD | 31.3% |
2016 FY | 853.14 Thousand USD | -19.47% |
2015 Q1 | 995.31 Thousand USD | -8.49% |
2015 Q2 | 887.96 Thousand USD | -10.79% |
2015 Q3 | 967.55 Thousand USD | 8.96% |
2015 FY | 1.05 Million USD | 6.44% |
2015 Q4 | 1.03 Million USD | 6.82% |
2014 Q4 | 1.08 Million USD | -1.92% |
2014 Q1 | 842.91 Thousand USD | 10.61% |
2014 Q2 | 1.01 Million USD | 20.08% |
2014 Q3 | 1.1 Million USD | 9.56% |
2014 FY | 995.31 Thousand USD | 18.08% |
2013 FY | 842.91 Thousand USD | 17.04% |
2013 Q4 | 762.09 Thousand USD | -4.91% |
2013 Q3 | 801.41 Thousand USD | 11.49% |
2013 Q2 | 718.8 Thousand USD | -0.2% |
2013 Q1 | 720.2 Thousand USD | -5.94% |
2012 Q4 | 765.68 Thousand USD | 12.89% |
2012 FY | 720.2 Thousand USD | 0.62% |
2012 Q1 | 715.79 Thousand USD | 12.13% |
2012 Q2 | 699.89 Thousand USD | -2.22% |
2012 Q3 | 678.23 Thousand USD | -3.09% |
2011 Q4 | 638.37 Thousand USD | 0.51% |
2011 Q1 | 426.47 Thousand USD | 21.26% |
2011 Q2 | 471.2 Thousand USD | 10.49% |
2011 Q3 | 635.11 Thousand USD | 34.79% |
2011 FY | 715.79 Thousand USD | 67.84% |
2010 Q1 | 376.05 Thousand USD | -6.63% |
2010 FY | 426.47 Thousand USD | 13.41% |
2010 Q4 | 351.71 Thousand USD | -23.45% |
2010 Q3 | 459.46 Thousand USD | 18.3% |
2010 Q2 | 388.4 Thousand USD | 3.29% |
2009 Q2 | 531.55 Thousand USD | 17.31% |
2009 Q1 | 453.13 Thousand USD | -5.12% |
2009 Q3 | 563.44 Thousand USD | 6.0% |
2009 FY | 376.05 Thousand USD | -17.01% |
2009 Q4 | 402.75 Thousand USD | -28.52% |
2008 Q3 | 496.21 Thousand USD | -19.35% |
2008 Q1 | 566.59 Thousand USD | -10.0% |
2008 FY | 453.13 Thousand USD | -20.03% |
2008 Q4 | 477.59 Thousand USD | -3.75% |
2008 Q2 | 615.25 Thousand USD | 8.59% |
2007 Q3 | 334.74 Thousand USD | 49.53% |
2007 Q2 | 223.87 Thousand USD | 3.54% |
2007 Q4 | 629.58 Thousand USD | 88.08% |
2007 FY | 566.59 Thousand USD | 162.04% |
2007 Q1 | 216.22 Thousand USD | 41.26% |
2006 Q2 | 11.08 Million USD | 17.39% |
2006 Q1 | 9.43 Million USD | 46.49% |
2006 FY | 216.22 Thousand USD | -97.71% |
2006 Q4 | 153.07 Thousand USD | -98.79% |
2006 Q3 | 12.63 Million USD | 14.05% |
2005 FY | 9.43 Million USD | 43.32% |
2005 Q1 | 6.58 Million USD | 64.91% |
2005 Q2 | 6.65 Million USD | 1.03% |
2005 Q3 | 5.34 Million USD | -19.63% |
2005 Q4 | 6.44 Million USD | 20.49% |
2004 Q4 | 3.99 Million USD | 31.41% |
2004 FY | 6.58 Million USD | 1802.79% |
2004 Q1 | 346.13 Thousand USD | 7.07% |
2004 Q2 | 309.26 Thousand USD | -10.65% |
2004 Q3 | 3.03 Million USD | 882.72% |
2003 Q4 | 323.28 Thousand USD | -9.75% |
2003 FY | 346.13 Thousand USD | -12.42% |
2003 Q2 | 372.26 Thousand USD | -5.81% |
2003 Q1 | 395.21 Thousand USD | -12.28% |
2003 Q3 | 358.22 Thousand USD | -3.77% |
2002 Q2 | 446.9 Thousand USD | -4.29% |
2002 Q1 | 466.95 Thousand USD | 18.74% |
2002 FY | 395.21 Thousand USD | -15.36% |
2002 Q3 | 438.5 Thousand USD | -1.88% |
2002 Q4 | 450.52 Thousand USD | 2.74% |
2001 Q3 | 508.99 Thousand USD | 12.15% |
2001 Q2 | 453.86 Thousand USD | -30.98% |
2001 Q1 | 657.55 Thousand USD | -5.02% |
2001 Q4 | 393.26 Thousand USD | -22.74% |
2001 FY | 466.95 Thousand USD | -28.99% |
2000 Q2 | 625.51 Thousand USD | 21.35% |
2000 FY | 657.55 Thousand USD | 27.57% |
2000 Q4 | 692.28 Thousand USD | 15.28% |
2000 Q3 | 600.5 Thousand USD | -4.0% |
2000 Q1 | 515.44 Thousand USD | -22.44% |
1999 Q1 | 477.95 Thousand USD | -4.41% |
1999 Q4 | 664.61 Thousand USD | -16.36% |
1999 Q3 | 794.57 Thousand USD | 20.18% |
1999 Q2 | 661.16 Thousand USD | 38.33% |
1999 FY | 515.44 Thousand USD | 7.84% |
1998 Q2 | 300 Thousand USD | -50.25% |
1998 Q3 | 400 Thousand USD | 33.33% |
1998 Q4 | 500 Thousand USD | 25.0% |
1998 FY | 477.95 Thousand USD | -20.74% |
1998 Q1 | 602.99 Thousand USD | 50.75% |
1997 Q2 | 100 Thousand USD | -57.31% |
1997 Q4 | 400 Thousand USD | 100.0% |
1997 FY | 602.99 Thousand USD | 157.42% |
1997 Q1 | 234.24 Thousand USD | -21.92% |
1997 Q3 | 200 Thousand USD | 100.0% |
1996 Q4 | 300 Thousand USD | 50.0% |
1996 FY | 234.24 Thousand USD | -15.33% |
1996 Q1 | 276.66 Thousand USD | -44.67% |
1996 Q2 | 400 Thousand USD | 44.58% |
1996 Q3 | 200 Thousand USD | -50.0% |
1995 Q1 | 200 Thousand USD | 0.0% |
1995 Q2 | 700 Thousand USD | 250.0% |
1995 Q3 | 500 Thousand USD | -28.57% |
1995 Q4 | 500 Thousand USD | 0.0% |
1995 FY | 276.66 Thousand USD | 38.33% |
1994 Q1 | 200 Thousand USD | 0.0% |
1994 Q2 | 200 Thousand USD | 0.0% |
1994 FY | 200 Thousand USD | 0.0% |
1994 Q3 | 200 Thousand USD | 0.0% |
1993 Q1 | 400 Thousand USD | 0.0% |
1993 FY | 200 Thousand USD | -50.0% |
1993 Q2 | 600 Thousand USD | 50.0% |
1993 Q3 | 200 Thousand USD | -66.67% |
1993 Q4 | 200 Thousand USD | 0.0% |
1992 Q2 | 400 Thousand USD | 0.0% |
1992 Q3 | 500 Thousand USD | 25.0% |
1992 Q4 | 400 Thousand USD | -20.0% |
1992 FY | 400 Thousand USD | 0.0% |
1992 Q1 | 400 Thousand USD | 33.33% |
1991 Q3 | 200 Thousand USD | 0.0% |
1991 FY | 400 Thousand USD | 100.0% |
1991 Q4 | 300 Thousand USD | 50.0% |
1991 Q2 | 200 Thousand USD | 0.0% |
1991 Q1 | 200 Thousand USD | 0.0% |
1990 FY | 200 Thousand USD | -33.33% |
1990 Q1 | 300 Thousand USD | 0.0% |
1990 Q3 | 200 Thousand USD | 0.0% |
1989 Q1 | 200 Thousand USD | 0.0% |
1989 FY | 300 Thousand USD | 50.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
BioElectronics Corporation | 16.62 Million USD | 91.299% |
Medical Supply International USA, Inc. | 677.61 Thousand USD | -113.445% |
Polarean Imaging plc | 2.58 Million USD | 43.952% |
Avitar, Inc. | 11.59 Million USD | 87.525% |
CVR Medical Corp. | - USD | -Infinity% |
IR-Med Inc. | 634 Thousand USD | -128.129% |
AVITA Medical, Inc. | 19.86 Million USD | 92.719% |
Manhattan Scientifics, Inc. | 2.11 Million USD | 31.712% |
Össur hf. | 688.8 Million USD | 99.79% |
Zecotek Photonics Inc. | 5.86 Million USD | 75.355% |
QHSLab, Inc. | 2.05 Million USD | 29.689% |
Wellstar International, Inc. | 55.99 Million USD | 97.417% |
Össur hf. | 688.8 Million USD | 99.79% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 16.08 Million USD | 91.006% |
Escalon Medical Corp. | 2.94 Million USD | 50.944% |
Aurora Spine Corporation | 6.65 Million USD | 78.262% |
BrainsWay Ltd. | 15.31 Million USD | 90.555% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 6.01 Million USD | 75.945% |
Hamilton Thorne Ltd. | 45.84 Million USD | 96.845% |
Vivos Inc. | 245 Thousand USD | -490.332% |
MicroPort Scientific Corporation | 2.48 Billion USD | 99.942% |
Kelyniam Global, Inc. | 1.01 Million USD | -42.787% |
REMSleep Holdings, Inc. | 275.61 Thousand USD | -424.769% |
CYduct Diagnostics, Inc. | 2.44 Million USD | 40.961% |
Nanomix Corporation | 14.81 Million USD | 90.237% |
Theraclion SA | 13.01 Million EUR | 88.888% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 5.12 Million USD | 71.774% |
Positron Corporation | 2.02 Million USD | 28.611% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.62 Million USD | 60.059% |
Lombard Medical, Inc. | 53.79 Million USD | 97.311% |
ALR Technologies Inc. | 24.5 Million USD | 94.098% |
Stratec SE | 271.97 Million USD | 99.468% |
Vycor Medical, Inc. | 4.31 Million USD | 66.503% |
Heart Tronics, Inc. | 1.09 Million USD | -32.111% |
Nu-Med Plus, Inc. | 2.35 Million USD | 38.683% |
Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 73.59% |
SANUWAVE Health, Inc. | 65.59 Million USD | 97.795% |
VMS Rehab Systems, Inc. | 201.36 USD | -718184.168% |
Guided Therapeutics, Inc. | 5.47 Million USD | 73.583% |
Ingen Technologies, Inc. | 5.7 Million USD | 74.668% |
Odyssey Group International, Inc. | 6.61 Million USD | 78.125% |
United American Healthcare Corporation | 119 Thousand USD | -1115.409% |
ECGI Holdings, Inc. | 11.94 Million USD | 87.887% |
Capital Group Holdings, Inc. | 1.32 Million USD | -9.241% |
Urologix, Inc. | 12.64 Million USD | 88.561% |
Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 73.196% |
Nexeon MedSystems Inc. | 8.48 Million USD | 82.949% |
SS Innovations International, Inc. | 11.18 Million USD | 87.064% |
Qualis Innovations, Inc. | 525.38 Thousand USD | -175.29% |
Smith & Nephew plc | 4.76 Billion USD | 99.97% |
NIOX Group Plc | 9.8 Million USD | 85.245% |
Fuse Medical, Inc. | 15.11 Million USD | 90.428% |
Broncus Holding Corporation | 10.43 Million USD | 86.136% |
Brain Scientific Inc. | 7.42 Million USD | 80.524% |
Pressure BioSciences, Inc. | 33.8 Million USD | 95.721% |
Health Logic Interactive Inc. | 794.08 Thousand USD | -82.14% |